BackAurora Cannabis Overview

Aurora Cannabis Current Cash

Latest current cash for ACB: $120M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$118.44M
↓ 36.33% YoYΔ $-67.59M vs prior year quarter

Peer trimmed avg / median

Loading

Aurora Cannabis Current Cash History

Loading

Aurora Cannabis vs. peers: Current Cash Comparison

Loading

Aurora Cannabis Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Aurora Cannabis (ACB) FAQ

Aurora Cannabis (ACB) currently reports a current cash of $120M as of June 2026. That compares with $190M in the prior-year period — down 36.3% year over year. Use the charts on this page to explore Aurora Cannabis's current cash history and peer comparisons.

Aurora Cannabis's current cash decreased from $190M to $120M — a 36.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aurora Cannabis reported $120M in current cash as of June 2026. That compares with $190M in the prior-year period — down 36.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $120M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aurora Cannabis, and consider following ACB for alerts when major investors trade the stock.

Aurora Cannabis is classified in the Healthcare sector. On current cash, it currently shows $120M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ACB with unrelated industries.